Company / Revenue
Bausch Health Companies Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$10.3B
FY2025
5-year range
$8.0B / $10.3B
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
#14 of 155
Health Care
What the data says
Among 155 Health Care companies, Bausch Health Companies Inc. is in the top 9% for revenue. Revenue has increased for 3 consecutive years, from $8.0B in FY2022 to $10.3B in FY2025.
Based on SEC 10-K filings.
$10.3B in FY2025 with a 5-year CAGR of +4.1%. Top quartile in the Health Care sector.
Improved from $8.4B to $10.3B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +8.5%
- 5-Year CAGR
- +4.1%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 155This company $10.3B Sector average $4.5B
▼
+129.6% above sector average
Key checks
Key Insights
- Bausch Health Companies Inc.'s revenue has grown for 3 consecutive years.
- 5-year CAGR of +4.1%, indicating consistent growth.
- In FY2025, revenue increased 6.7% year-over-year.
- Ranks #14 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.3B | +6.7% |
| FY2024 | $9.6B | +14.1% |
| FY2023 | $8.4B | +5.1% |
| FY2022 | $8.0B | -4.8% |
| FY2021 | $8.4B | +0.6% |
| FY2020 | $8.4B | -3.9% |
| FY2019 | $8.7B | -9.8% |
| FY2018 | $9.7B | +358.7% |
| FY2017 | $2.1B | -11.1% |
| FY2016 | $2.4B | -77.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026